X4 Pharmaceuticals Inc (XFOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 563 | 0 | 0 | 0 | 0 |
| Cost of Goods | 268 | N/A | N/A | 0 | N/A |
| Gross Profit | 295 | N/A | N/A | N/A | N/A |
| Operating Expenses | -70,540 | 37,289 | 25,199 | 27,214 | 25,805 |
| Operating Income | 71,103 | -37,289 | -25,199 | -27,214 | -25,805 |
| Interest Expense | 2,176 | 1,874 | 1,886 | 1,634 | 1,148 |
| Other Income | 21,924 | -12,584 | 7,988 | 26,569 | -28,744 |
| Pre-tax Income | 90,851 | -51,747 | -19,097 | -2,279 | -55,697 |
| Income Tax | 18 | 19 | 33 | 26 | 15 |
| Net Income Continuous | 90,833 | -51,766 | -19,130 | -2,305 | -55,712 |
| Net Income | $90,833 | $-51,766 | $-19,130 | $-2,305 | $-55,712 |
| EPS Basic Total Ops | 13.59 | -7.77 | -2.10 | -0.30 | -9.91 |
| EPS Basic Continuous Ops | 13.60 | -7.77 | -1.88 | -0.35 | -9.92 |
| EPS Diluted Total Ops | 13.57 | -7.77 | -2.10 | -0.30 | -9.91 |
| EPS Diluted Continuous Ops | 13.57 | -7.77 | -1.88 | -0.35 | -9.92 |
| EPS Diluted Before Non-Recurring Items | -2.10 | -7.81 | -3.00 | N/A | N/A |
| EBITDA(a) | $71,297 | $-37,227 | $-25,137 | $-27,110 | $-25,679 |